These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28433598)

  • 81. SNTB1 regulates colorectal cancer cell proliferation and metastasis through YAP1 and the WNT/β-catenin pathway.
    Zhang H; Li Z; Jiang J; Lei Y; Xie J; Liu Y; Yi B
    Cell Cycle; 2023 Sep; 22(17):1865-1883. PubMed ID: 37592763
    [TBL] [Abstract][Full Text] [Related]  

  • 82. lncRNA cytoskeleton regulator RNA (CYTOR): Diverse functions in metabolism, inflammation and tumorigenesis, and potential applications in precision oncology.
    Ou C; He X; Liu Y; Zhang X
    Genes Dis; 2023 Mar; 10(2):415-429. PubMed ID: 37223495
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
    Zhang Y; Zhan L; Li J; Jiang X; Yin L
    Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
    Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
    Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Human umbilical cord mesenchymal stem cells conditioned medium exerts anti-tumor effects on KGN cells in a cell density-dependent manner through activation of the Hippo pathway.
    Wan W; Miao Y; Niu Y; Zhu K; Ma Y; Pan M; Ma B; Wei Q
    Stem Cell Res Ther; 2023 Mar; 14(1):46. PubMed ID: 36941685
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hsa_circ_0001658 accelerates the progression of colorectal cancer through miR-590-5p/METTL3 regulatory axis.
    Lu Y; Wang XM; Li ZS; Wu AJ; Cheng WX
    World J Gastrointest Oncol; 2023 Jan; 15(1):76-89. PubMed ID: 36684043
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Construction of CeRNA regulatory network based on WGCNA reveals diagnosis biomarkers for colorectal cancer.
    Xiang J; Gao L; Jing HY; Liu YX; Wang HF; Chang ZW; Liu SH; Yu L; Wang GY
    BMC Cancer; 2022 Sep; 22(1):991. PubMed ID: 36115953
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Relationship between Yes-Associated Protein 1 and Prognosis of Digestive System Neoplasm: Quantitative Analysis and Bioinformatics Analysis Based on 4023 Patients.
    Yuan Yuan L; Shuai W; Yuan-Peng Z; Ting J; Wei X; Yu-Qin H
    Evid Based Complement Alternat Med; 2022; 2022():3798694. PubMed ID: 35911146
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.
    Wang Y; Nie H; Li H; Liao Z; Yang X; He X; Ma J; Zhou J; Ou C
    Front Med (Lausanne); 2022; 9():888093. PubMed ID: 35865173
    [TBL] [Abstract][Full Text] [Related]  

  • 90. FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance.
    Li Z; Shi J; Zhang N; Zheng X; Jin Y; Wen S; Hu W; Wu Y; Gao W
    J Cancer; 2022; 13(8):2528-2539. PubMed ID: 35711849
    [TBL] [Abstract][Full Text] [Related]  

  • 91. miR-590-5p Overexpression Alleviates
    Shang L; Peng T; Chen X; Yan Z; Wang J; Gao X; Chang C
    Anal Cell Pathol (Amst); 2022; 2022():7657995. PubMed ID: 35310934
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Overexpression of the long non-coding RNA
    Bu C; Wang B; Zhang D; Mao Z; Pu C
    Transl Cancer Res; 2019 Feb; 8(1):35-43. PubMed ID: 35116731
    [TBL] [Abstract][Full Text] [Related]  

  • 93. MiR-590 suppresses the progression of non-small cell lung cancer by regulating YAP1 and Wnt/β-catenin signaling.
    Hao X; Su A
    Clin Transl Oncol; 2022 Mar; 24(3):546-555. PubMed ID: 35031966
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic Options.
    Cione E; Cannataro R; Gallelli L; De Sarro G; Caroleo MC
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959658
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer.
    Lu S; Ding X; Wang Y; Hu X; Sun T; Wei M; Wang X; Wu H
    Front Cell Dev Biol; 2021; 9():772542. PubMed ID: 34938735
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Long Non-Coding RNA: A Potential Strategy for the Diagnosis and Treatment of Colorectal Cancer.
    Chen S; Fang Y; Sun L; He R; He B; Zhang S
    Front Oncol; 2021; 11():762752. PubMed ID: 34778084
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical Significance and Integrative Analysis of the SMC Family in Hepatocellular Carcinoma.
    Nie H; Wang Y; Yang X; Liao Z; He X; Zhou J; Ou C
    Front Med (Lausanne); 2021; 8():727965. PubMed ID: 34527684
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Exosomal long non-coding RNAs: Emerging players in cancer metastasis and potential diagnostic biomarkers for personalized oncology.
    Nie H; Liao Z; Wang Y; Zhou J; He X; Ou C
    Genes Dis; 2021 Nov; 8(6):769-780. PubMed ID: 34522707
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinical significance of serum miR-129-5p in patients with diabetes mellitus presenting macrovascular complications.
    He XY; Ou CL
    World J Diabetes; 2021 Aug; 12(8):1282-1291. PubMed ID: 34512893
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Role of exosomal long non-coding RNAs in colorectal cancer.
    Sun R; He XY; Mei C; Ou CL
    World J Gastrointest Oncol; 2021 Aug; 13(8):867-878. PubMed ID: 34457192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.